Importantly, studies involving the effect of treatment at early life in the absence of microbiota using germ-free mice as well as investigations of the direct role of β-glucan receptor, Dectin-1, at these ages are needed to further support the microbiota dependent mechanisms of protection from T1D achieved upon treatment with YBG. The gene discussed is CLEC7A; the disease is type 1 diabetes mellitus.